These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 29132061)

  • 1. Synchronous peritoneal metastases of small bowel adenocarcinoma: Insights into an underexposed clinical phenomenon.
    Legué LM; Simkens GA; Creemers GM; Lemmens VEPP; de Hingh IHJT
    Eur J Cancer; 2017 Dec; 87():84-91. PubMed ID: 29132061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrence and Survival Outcomes After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Small Bowel Adenocarcinoma.
    Saxena A; Valle SJ; Liauw W; Morris DL
    Anticancer Res; 2017 Oct; 37(10):5737-5742. PubMed ID: 28982894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peritoneal metastases from small bowel cancer: Results of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in The Netherlands.
    van Oudheusden TR; Lemmens VE; Braam HJ; van Ramshorst B; Meijerink J; te Velde EA; Mehta AM; Verwaal VJ; de Hingh IH
    Surgery; 2015 Jun; 157(6):1023-7. PubMed ID: 25818658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Metastases From a Small Bowel Adenocarcinoma: Multi-Institutional Experience.
    Liu Y; Yonemura Y; Levine EA; Glehen O; Goere D; Elias D; Morris DL; Sugarbaker PH; Tuech JJ; Cashin P; Spiliotis JD; de Hingh I; Ceelen W; Baumgartner JM; Piso P; Katayama K; Deraco M; Kusamura S; Pocard M; Quenet F; Fushita S;
    Ann Surg Oncol; 2018 May; 25(5):1184-1192. PubMed ID: 29484565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for the treatment of synchronous peritoneal carcinomatosis of colorectal origin in the Netherlands.
    Razenberg LG; van Gestel YR; Creemers GJ; Verwaal VJ; Lemmens VE; de Hingh IH
    Eur J Surg Oncol; 2015 Apr; 41(4):466-71. PubMed ID: 25680955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histological subtype and systemic metastases strongly influence treatment and survival in patients with synchronous colorectal peritoneal metastases.
    Simkens GA; Razenberg LG; Lemmens VE; Rutten HJ; Creemers GJ; de Hingh IH
    Eur J Surg Oncol; 2016 Jun; 42(6):794-800. PubMed ID: 27055946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of peritoneal metastases from small bowel adenocarcinoma.
    Rovers KP; de Bree E; Yonemura Y; de Hingh IH
    Int J Hyperthermia; 2017 Aug; 33(5):571-578. PubMed ID: 27919181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory bowel disease drastically affects the prognosis of patients treated for peritoneal metastases with combined cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: A multicenter study.
    Hammoudi N; Eveno C; Lambert J; Maillet M; Glehen O; Goere D; Lourenco N; Allez M; Aparicio T; Pocard M; Gornet JM;
    Eur J Surg Oncol; 2018 Jun; 44(6):799-804. PubMed ID: 29650418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Dissemination from Small Bowel Malignancy: Results from a Single Specialized Center.
    Liu Y; Ishibashi H; Takeshita K; Mizumoto A; Hirano M; Sako S; Takegawa S; Takao N; Ichinose M; Yonemura Y
    Ann Surg Oncol; 2016 May; 23(5):1625-31. PubMed ID: 26717938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postoperative complications affect long-term outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis.
    Lee L; Alie-Cusson F; Dubé P; Sideris L
    J Surg Oncol; 2017 Aug; 116(2):236-243. PubMed ID: 28409831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term survival after hyperthermic intraperitoneal chemotherapy using mitomycin C or oxaliplatin in colorectal cancer patients with synchronous peritoneal metastases: A nationwide comparative study.
    Bakkers C; van Erning FN; Rovers KP; Nienhuijs SW; Burger JW; Lemmens VE; Aalbers AG; Kok NF; Boerma D; Brandt AR; Hemmer PH; van Grevenstein WM; de Reuver PR; Tanis PJ; Tuynman JB; de Hingh IH
    Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1902-1907. PubMed ID: 32340819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of progression in high-grade appendiceal or colorectal peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Baumgartner JM; Tobin L; Heavey SF; Kelly KJ; Roeland EJ; Lowy AM
    Ann Surg Oncol; 2015 May; 22(5):1716-21. PubMed ID: 25145504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of survival in patients with high-grade peritoneal metastases undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Van Sweringen HL; Hanseman DJ; Ahmad SA; Edwards MJ; Sussman JJ
    Surgery; 2012 Oct; 152(4):617-24; discussion 624-5. PubMed ID: 22943843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRS-HIPEC Prolongs Survival but is Not Curative for Patients with Peritoneal Carcinomatosis of Gastric Cancer.
    Boerner T; Graichen A; Jeiter T; Zemann F; Renner P; März L; Soeder Y; Schlitt HJ; Piso P; Dahlke MH
    Ann Surg Oncol; 2016 Nov; 23(12):3972-3977. PubMed ID: 27313067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for patients with peritoneal metastases of urachal cancer.
    Mertens LS; Behrendt MA; Mehta AM; Stokkel L; de Jong J; Boot H; Horenblas S; van der Heijden MS; Moonen LM; Aalbers AGJ; Meinhardt W; van Rhijn BWG
    Eur J Surg Oncol; 2019 Sep; 45(9):1740-1744. PubMed ID: 31003721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Prognostic Factors and Adjuvant Chemotherapy in Patients With Small Bowel Adenocarcinoma Who Underwent Curative Resection.
    Aydin D; Sendur MA; Kefeli U; Unal OU; Tastekin D; Akyol M; Tanrikulu E; Ciltas A; Ustaalioglu BB; Uysal M; Esbag O; Yazilitas D; Tanrıverdi O; Bilici A; Arpaci E; Berk V; Yetisyigit T; Ozdemir NY; Oztop I; Alacacioglu A; Aydin O; Ozcelik M; Yildirim E; Dinc N; Gumus M
    Clin Colorectal Cancer; 2017 Sep; 16(3):220-227. PubMed ID: 27670893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of colorectal cancer patients at high risk of peritoneal metastases.
    Shariff U; Seretis C; Youssef H
    J BUON; 2015 May; 20 Suppl 1():S71-9. PubMed ID: 26051336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased Survival of Patients with Synchronous Colorectal Peritoneal Metastases Receiving Preoperative Chemotherapy Before Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
    Devilee RA; Simkens GA; van Oudheusden TR; Rutten HJ; Creemers GJ; Ten Tije AJ; de Hingh IH
    Ann Surg Oncol; 2016 Sep; 23(9):2841-8. PubMed ID: 27044447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefit of cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy in patients with isolated peritoneal metastases from colorectal cancer.
    Piso P; Stierstorfer K; Gerken M; Klinkhammer-Schalke M
    Int J Colorectal Dis; 2018 Nov; 33(11):1559-1567. PubMed ID: 30132068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy for the treatment of primary peritoneal serous carcinoma: Results of a Chinese retrospective study.
    Sun JH; Ji ZH; Peng KW; Wu HT; Zhang Q; Yonemura Y; Li Y
    Int J Hyperthermia; 2016 May; 32(3):289-97. PubMed ID: 26982735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.